Literature DB >> 29353318

Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.

Takeshi Saraya1, Kosuke Ohkuma2, Takayasu Watanabe2, Sunao Mikura2, Fumi Kobayashi2, Junpei Aso2, Hiroki Nunokawa2, Kojiro Honda2, Yukari Ogawa2, Masaki Tamura2, Mitsuru Sada2, Miku Oda2, Manami Inoue2, Takuma Yokoyama2, Daisuke Kurai2, Haruyuki Ishii2, Hirokazu Kimura3, Hajime Takizawa2.   

Abstract

PURPOSE: We studied the diagnostic value of cytokines, including vascular endothelial growth factor (VEGF), transforming growth factor-β (TGF-β), and interleukin-8 (IL-8), and the ratio of lactate dehydrogenase (LDH) to adenosine deaminase (ADA) in pleural fluid.
METHODS: Prospective analysis of 44 inpatients or outpatients with pleural fluid, from December 2016 to March 2017 was conducted.
RESULTS: We enrolled patients with malignant pleural effusion (MPE, N = 15), empyema (N = 11), parapneumonic effusion (PPE, N = 7), chronic renal failure (CRF)/chronic heart failure (CHF) (N = 7), and tuberculous pleural effusion (TBPE, N = 4). The pleural fluid values of IL-8 and VEGF were significantly higher in empyema patients than in CRF/CHF or PPE patients. In all patients, the pleural fluid VEGF and IL-8 values were significantly positively correlated (r = 0.405, p = 0.006; r = 0.474, p = 0.047, respectively). TGF-β was elevated in patients with empyema, PPE, TBPE, and MPE. The pleural LDH-to-ADA ratio in patients with MPE or empyema/PPE was significantly higher than in patients with CRF/CHF or TBPE. LDH and ADA levels correlated significantly only in patients with MPE (r = 0.648, p = 0.009) and empyema/PPE (r = 0.978, p < 0.001).
CONCLUSIONS: VEGF and IL-8 production in the pleural cavity appear to accelerate the progression of PPE to empyema, by enhancing vascular permeability associated with inflammation. Sequential sampling would be needed to confirm this. The pleural LDH/ADA ratio may be a useful diagnostic tool for discriminating between various pleural effusion etiologies.

Entities:  

Keywords:  Interleukin-8; Pleural LDH/ADA ratio; Transforming growth factor-β; Vascular endothelial growth factor; Vascular permeability

Mesh:

Substances:

Year:  2018        PMID: 29353318     DOI: 10.1007/s00408-018-0090-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  8 in total

1.  Clinical practice. Pleural effusion.

Authors:  Richard W Light
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

2.  Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.

Authors:  Alfonso Fiorelli; Giovanni Vicidomini; Marina Di Domenico; Filomena Napolitano; Gaetana Messina; Floriana Morgillo; Fortunato Ciardiello; Mario Santini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-12-20

3.  Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions.

Authors:  D Cheng; Y C Lee; J T Rogers; E A Perkett; J P Moyers; R M Rodriguez; R W Light
Journal:  Chest       Date:  2000-12       Impact factor: 9.410

Review 4.  Immunological mechanisms in pleural disease.

Authors:  V B Antony
Journal:  Eur Respir J       Date:  2003-03       Impact factor: 16.671

Review 5.  Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.

Authors:  G L Colice; A Curtis; J Deslauriers; J Heffner; R Light; B Littenberg; S Sahn; R A Weinstein; R D Yusen
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

Review 6.  The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.

Authors:  Michael Bradshaw; Aaron Mansfield; Tobias Peikert
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

7.  Pleural fluid analysis: standstill or a work in progress?

Authors:  T Hassan; M Al-Alawi; S H Chotirmall; N G McElvaney
Journal:  Pulm Med       Date:  2012-02-01

8.  A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.

Authors:  Naoki Tsujimoto; Takeshi Saraya; Richard W Light; Yayoi Tsukahara; Takashi Koide; Daisuke Kurai; Haruyuki Ishii; Hirokazu Kimura; Hajime Goto; Hajime Takizawa
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

  8 in total
  6 in total

1.  Age : pleural fluid ADA ratio and other indicators for differentiating between tubercular and malignant pleural effusions.

Authors:  Jiupeng Zhou; Yuanli Yang; Yongfeng Zhang; Heng Liu; Quanli Dou
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

2.  Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

Review 3.  Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?

Authors:  Nicola Principe; Joel Kidman; Richard A Lake; Willem Joost Lesterhuis; Anna K Nowak; Alison M McDonnell; Jonathan Chee
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

4.  A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.

Authors:  Takeshi Saraya; Kosuke Ohkuma; Takashi Koide; Hajime Goto; Hajime Takizawa; Richard W Light
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

5.  Diagnostic method for malignant pleural effusion distinguishing malignant mesothelioma from lung cancer using pleural carcinoembryonic antigen and hyaluronic acid levels.

Authors:  Takeshi Saraya; Kosuke Ohkuma; Masachika Fujiwara; Haruyuki Ishii
Journal:  Medicine (Baltimore)       Date:  2022-01-07       Impact factor: 1.889

6.  Characteristics of pleural effusion with a high adenosine deaminase level: a case-control study.

Authors:  Masafumi Shimoda; Aya Hirata; Yoshiaki Tanaka; Kozo Morimoto; Takashi Yoshiyama; Kozo Yoshimori; Takeshi Saraya; Haruyuki Ishii; Ken Ohta
Journal:  BMC Pulm Med       Date:  2022-09-21       Impact factor: 3.320

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.